Incidence of pneumonia Defined as patient admitted to hospital with a diagnosis of pneumonia Dose: 2 g per day · school‐aged children (6 to 15 years) and marine corps recruits (mean age 18.5 years)
It is very uncertain whether vitamin C changes incidence of pneumonia Defined as patient admitted to hospital with… compared with placebo (very low certainty).
1 finding from 1 review
Prevalance of pneumonia · school‐aged children (6 to 15 years) and marine corps recruits (mean age 18.5 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (pneumonia-associated) · school‐aged children (6 to 15 years) and marine corps recruits (mean age 18.5 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (urticaria) Defined as participants reporting urticaria (hives) Dose: 2 g per day · school‐aged children (6 to 15 years) and marine corps recruits (mean age 18.5 years)
It is very uncertain whether vitamin C changes adverse effects (urticaria) Defined as participants reporting… compared with placebo (very low certainty).
1 finding from 1 review
Duration of illness · children under 5 years of age
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Clinical cure · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (pneumonia-associated) · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
CRM197‐PCV7in low‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
1 finding from 1 review
CRM197‐PCV7in high‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
1 finding from 1 review
OMPC‐PCV7in low‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
1 finding from 1 review
PHiD‐CV10in low‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
1 finding from 1 review
PHiD‐CV11in low‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
1 finding from 1 review
Adverse effects · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
CRM197‐PCV7in low‐risk infants OMPC‐PCV7in low‐risk infants PHiD‐PC10 and PHiD‐PC11 in low‐risk infants CRM197‐PCV7/9 and CRM197‐PCV7 plus TIVin older children · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
1 finding from 1 review
Mortality ( · children aged from 29 days to 12 years with pneumonia
Chest physiotherapy may leads to lower mortality ( compared with no chest physiotherapy (low certainty).
1 finding from 1 review
Length of hospital stay · children aged from 29 days to 12 years with pneumonia
Chest physiotherapy showed no clear difference in duration of hospital stay (days) ( compared with no chest physiotherapy (low certainty).
1 finding from 1 review
Clinical resolution · children aged from 29 days to 12 years with pneumonia
Chest physiotherapy showed no clear difference in time to clinical resolution (all parameters) ( compared with no chest physiotherapy (low certainty).
1 finding from 1 review
Adverse events (number of events) ( · children aged from 29 days to 12 years with pneumonia
Chest physiotherapy showed no clear difference in adverse events (number of events) ( compared with no chest physiotherapy (low certainty).
1 finding from 1 review
Proportion of children with AOM (overall) · children up to age 18 years
Probiotic probably leads to lower proportion of children with AOM (overall) compared with placebo (moderate certainty).
1 finding from 1 review